Compare Mobility Global Inc. Common Stock (MBGL) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mobility Global Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Mobility Global Inc. Common Stock trades at $17.85 (market cap $5.80B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Mobility Global Inc. Common Stock is far larger — about 2.7× NeoGenomics Inc. Common Stock's market cap, and Mobility Global Inc. Common Stock pays a 1.33% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mobility Global Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MBGL | NEO | |
|---|---|---|
Market Cap | $5.80B | $2.14B |
Volume | 2,595,123 | 2,228,400 |
Sector | Technology | Health |
52-Week High | $22.26 | $19.91 |
52-Week Low | $17.15 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $7.62B | $2.44B |
Dividend Yield | 1.33% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mobility Global Inc. Common Stock
Mobility Global Inc. provides automotive data and analytics across the vehicle lifecycle, operating brands including CARFAX, automotiveMastermind, Polk Automotive Solutions, and Market Scan for automakers, dealers, and consumers.
Read more on MBGL →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
